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LIMITATIONS ON STATISTICS AND DISCLOSURE OF FINDINgS
The statistics contained in this report are the most current as at the time of publication. 
The statistical data contained in this report is primarily provided to the ACC by the 
Australian Customs and Border Protection Service, the Australian Federal Police and state 
and territory police services. These agencies also contribute intelligence which enables the 
Commission to compile a national picture of the methylamphetamine problem.1 
Statistics presented in this report likely under-represent the size of the 
methylamphetamine market due to a legacy of recording in law enforcement databases.  
User surveys, another method of estimating the size of the market, also under-estimate 
user numbers for a range of reasons.
Further to this, legal provisions prevent the ACC from publically disclosing detailed 
information about the nature of the matters contained in this report. This includes the 
disclosure of information specifically referencing particular individuals or groups involved 
in the methylamphetamine market. As such, the report focuses on describing the 
broad nature of the threats and includes intelligence judgments about the likely future 
trajectory of these issues.
1 Some statistics, particularly those which cover international markets, take several years to produce, and therefore 
may seem dated.
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ceo ForeWorD
 
On my first day at the Australian Crime Commission (ACC) the 2012–13 Illicit Drug 
Data Report was released at one of Victoria’s oldest hospitals, The Alfred. This hospital 
was a symbol representing one of many hospital emergency rooms across the country 
increasingly occupied by patients on methylamphetamine. Methylamphetamine places a 
huge burden on our healthcare system and its workers, ambulance officers, police and the 
community—those who see first hand the chaos created by this drug on a daily basis. 
Over the past five years, intelligence and data continue to show an emerging 
national and international concern with methylamphetamine, particularly crystal 
methylamphetamine (‘ice’). This is demonstrated by the November 2014 seizure  
by the New South Wales Joint Organised Crime Group of two tonnes of MDMA and  
more than 800 kilograms of methylamphetamine—worth a combined estimated 
street value of $1.5 billion. It was demonstrated again in March 2015 by the detection 
of 230 kilograms of liquid methylamphetamine by the Polaris Joint Waterfront 
Taskforce following a one year investigation. The availability and addictive nature of 
methylamphetamine has created new demand in urban, rural and disadvantaged 
communities where its destructive impact is growing at a significant rate. 
Serious and organised crime groups are thriving on the profits generated through 
methylamphetamine. The price paid for methylamphetamine in Australia is among the 
highest in the world. This has driven interest in the market by transnational organised 
crime groups with access to offshore industrial-scale manufacturing, as well as by  
domestic organised crime groups. Significant border detections, national seizures and 
arrests highlight the continued focus by law enforcement agencies on the response, as 
has the work of respective health and education professionals. 
Notwithstanding this, the growing ‘take up’ rate of methylamphetamine use and 
consequential community harms, along with  continued concern among  a broad cross-
section of the Australian community, has led the ACC to develop a concise unclassified 
intelligence picture on the threat posed by methylamphetamine. 
In releasing this report, I hope to inform all members of the Australian community who are 
concerned by the impact of methylamphetamine, so that they can better understand the 
threat, the role of serious and organised crime in the problem and the need to collectively 
work on effective responses. This report will contribute to Australia’s collective response 
efforts to what is becoming a significant national issue.  
 
 
 
Chris Dawson APM 
Chief Executive Officer 
Australian Crime Commission
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Aim
 
This report aims to provide a concise understanding of the nature of organised crime 
involvement in the Australian methylamphetamine market.  
The ACC monitors all illicit drug markets through its High Risk and Emerging Drugs Special 
Operation. Through this work, the ACC has assessed that methylamphetamine poses the 
greatest threat to the Australian public of all illicit drug types. 
The ACC’s annual Illicit Drug Data Report provides a detailed and comprehensive 
statistical picture of the illicit drug threat to Australia and provides an in-depth statistical 
analysis of the illicit drug market. The Australian Methylamphetamine Market:  
The National Picture is a complementary intelligence report.  
This report provides a brief summation of the national picture of the 
methylamphetamine threat. It explores the international and national dimensions 
of the methylamphetamine market, outlines the role of organised crime in driving 
the Australian market, the nature of the market, and the harms associated with 
methylamphetamine use. It also examines the diversion of precursor chemicals required 
to produce methylamphetamine in clandestine laboratories. It does this by consolidating 
open source information with operational and strategic intelligence collected by the ACC 
and Commonwealth, state and territory law enforcement agencies. 
The release of this report is designed to: 
  inform the widest possible audience, including those who are not privy to classified 
law enforcement intelligence
  generate discussion and dialogue about what can be done to tackle the 
methylamphetamine problem
  enable individuals, friends and families to understand the nature of the harms caused 
by methylamphetamine and influence those around them to minimise harm
  inform the national response to the methylamphetamine market. 
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oVerVieW
 
Methylamphetamine is a synthetic stimulant drug and a type of amphetamine-type 
stimulant that is illegal in all Australian jurisdictions. Methylamphetamine comes in 
several forms, including tablet, powder, crystal and oil. The most commonly available 
form in Australia is crystalline (‘ice’) followed by powder (‘speed’).
Of all illicit drugs, the ACC assesses that methylamphetamine, and in particular crystal 
methylamphetamine, poses the highest risk to the Australian community and is of 
significant national concern. 
The ACC has identified significant changes in the nature and scale of the 
methylamphetamine market since 2010, and particularly since 2013. The purity has 
increased and crystal methylamphetamine is now the dominant form of the drug.
Of particular concern is the diversification in the supply of methylamphetamine to 
the market. Where domestic production has traditionally been adequate to supply a 
relatively stable user base, since 2010 there has been a considerable increase in the 
number and weight of detections at the Australian border. Several seizure records 
have been set, and this upward trend is continuing. This growth has occurred without 
a concurrent fall in domestic production, as indicated by the number of clandestine 
laboratory detections and the high volume of precursor seizures. 
Serious and organised crime is driving these trends and user demand. 
More than 60 per cent of Australia’s highest risk criminal targets, including transnational 
targets, are involved in the methylamphetamine market. The majority of these targets 
are involved in multiple drug markets. The growth in scale of serious and organised crime 
involvement is the result of the significant profits to be made, the move by crime groups 
to poly-drug2 trafficking and an increase by users in poly-drug use.
Serious and organised crime groups are also increasingly involved in the importation 
and trafficking of precursor chemicals, and are adept at developing new manufacturing 
techniques to avoid controls over sales of key precursor chemicals. 
The ACC assesses that the Australian methylamphetamine market will continue to grow 
in the short to medium term. This expansion can only be addressed by the collective 
efforts of the Australian Government, state and territory governments, non-government 
organisations, industry and the community.
2 More than one drug type.
6THE AUSTRALIAN METHYLAMPHETAMINE MARKET—THE NATIONAL PICTURE 
AUSTRALIAN CRIME COMMISSION
THE AUSTRALIAN METHYLAMPHETAMINE MARKET—THE NATIONAL PICTURE 
AUSTRALIAN CRIME COMMISSION
The meThylAmpheTAmine 
mArkeT
INTERNATIONAL TRENDS 
Amphetamine-type stimulants, such as methylamphetamine, are the second most 
widely used illicit drug in the world, following cannabis. In 2014, the United Nations 
Office on Drugs and Crime (UNODC) reported an estimated 13.9 million to 54.8 million 
users worldwide.3 
Since 1990, methylamphetamine manufacture has been reported in 70 countries, with 
clandestine laboratories being located in new locations every year.4 Crime groups in China, 
Burma, Indonesia, Mexico and Iran are among the largest producers of methylamphetamine. 
Emerging production hubs include the Philippines, Russia and Ghana. 
Global amphetamine seizures have grown in weight each year since 2010. In 2012, the 
weight seized by law enforcement increased by 15 per cent—from 123 tonnes in 2011 to 
144 tonnes in 2012. Methylamphetamine comprised approximately 80 per cent of these 
seizures.5
Increases in border detections of methylamphetamine worldwide provide further 
evidence of the growth of the market. The World Customs Organization (WCO) reported 
methylamphetamine border detections increased from about  9 tonnes in 2012 to 12 tonnes 
in 2013.6 
Transnational serious and organised crime groups feature prominently in the global 
methylamphetamine market. These groups use multiple countries as transit points 
for trafficking methylamphetamine and precursor chemicals to and from Asia and the 
Americas, Australia and New Zealand. Drug trafficking syndicates from Africa and Iran, 
and others with links to China and Hong Kong, traffic methylamphetamine into and 
through South-East Asia by air transport and sea cargo containers. Indian drug trafficking 
networks smuggle precursor chemicals to drug manufacturing locations in nearby 
countries.
3 UNODC 2014, Global synthetic drugs assessment: Amphetamine-type stimulants and new psychoactive substances, 
UNODC, Vienna.
4 UNODC 2013, Global SMART Update, 10 September, Vol. 10, UNODC, Vienna.
5 UNODC 2014, World Drug Report 2014, UNODC, Vienna.
6 WCO 2014, Illicit Trade Report 2013, WCO, Brussels. 
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cAse sTuDy 
DruG cArTel inVolVemenT in The 
meThylAmpheTAmine mArkeT
Mexican drug trafficking cartels are becoming increasingly involved in the global 
methylamphetamine market. These groups have actively sought international 
criminal partners in Australia, Canada, Ghana, Nigeria and Spain. 
The cartels are using these partnerships to expand their markets throughout Europe, 
Africa, Asia and the Pacific. They are taking advantage of existing distribution 
networks, using transiting routes through a number of countries to conceal country 
of origin, and exploiting countries with weak regulatory or enforcement regimes.
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INTErNATIoNAl TrENdS (CoNTINuEd) 
It is difficult to accurately assess the impact of the global trends on the Australian 
market. However, the production and availability of methylamphetamine worldwide has 
been an influencing factor in the emergence of imported methylamphetamine on the 
Australian market. 
There is a legitimate market for the chemicals used to produce methylamphetamine, 
which create opportunities for organised crime to illegally divert these chemicals for 
methylamphetamine production. Countries with large chemical industries, such as China 
and India, are particularly targeted by transnational organised crime groups. Once obtained 
these chemicals may be illicitly shipped internationally to end user countries, or used in 
clandestine laboratories in the country of origin. 
Many Australian organised crime groups have capacity to operate within countries where 
precursors are freely available or in partnership with groups from those countries. Many 
essential precursors are not controlled internationally, at the border, or domestically due 
to their varied legitimate uses. Illicit importations of controlled precursors have been 
detected through the identification of mislabelling and concealments, or importations 
in quantities which would seem inconsistent with the nominated intended use. An 
emerging method is precursor masking, in which the chemical structure of the substance 
is altered to avoid detection at initial screening.
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cAse sTuDy 
orGAniseD criminAl shiFTs in response To 
leGislATiVe AnD reGulATory reForm
The evolution of the ContacNT market provides a useful case study of the ability 
of organised crime groups to adapt to changes in the availability and quality of 
precursors. ContacNT is a brand name of a cold and flu medication produced for the 
Chinese domestic market. It was valuable to organised crime groups because until 
relatively recently it contained the highest percentage of pseudoephedrine (PSE) of 
any cold and flu medication and its purchase was, at the time, unregulated in China. 
Prior to 2009, detections at the Australian border were limited, although it was 
known to be regularly shipped illicitly to New Zealand. From 2009 until 2011 
detections increased, followed by a significant increase from 2011 to 2013. It was in 
this period that Project SToP (which is focused on preventing the diversion of PSE) 
had been widely adopted and sourcing PSE domestically became more difficult. 
In 2009 there were nine detections of ContacNT totalling 20.4 kilograms. In the 
period 2011–13, more than one tonne of the substance was detected. ContacNT is 
generally concealed within food or consumer goods, and has been identified as being 
re-routed from China through third countries prior to arrival in Australia, almost 
certainly in an attempt to avoid targeting by the Australian Customs and Border 
Protection Service.
Since 2012, China has begun implementing regulations around PSE products. As 
these regulations have taken affect, the product has been more difficult to divert. 
Additionally, it is reported that ContacNT now contains a lower percentage of PSE.  
In demonstrating their ability to adapt quickly to changes in their environment, 
intelligence suggests that, as a result of these changes in China, organised crime 
groups have shifted their focus to importing pure ephedrine.
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NATIONAL TRENDS 
The Australian methylamphetamine market remained fairly stable in the decade to 
2010. However, in the past five years there has been significant growth in the detected 
importation, manufacture and supply of the drug. Following cannabis and MDMA, 
methylamphetamine is reported to be the third most commonly used illicit drug in 
Australia among people who have recently used drugs. 
The purity of methylamphetamine has also increased, making its use even more 
dangerous, and there has been a growth in the availability and use of crystal 
methylamphetamine. Australian users of methylamphetamine pay a premium price 
compared to those in other countries, making importations to Australia attractive 
and profitable. According to the UNODC, the average street price per gram of 
methylamphetamine in China is USD$80, whereas in Australia it is USD$500. Wholesale 
prices in Australia have been recorded as ranging from A$90 000 to A$325 000 per 
kilogram. As with methylamphetamine, the precursor chemical market is characterised 
by high demand and high profits.
Of all illicit drugs, the ACC assesses that methylamphetamine, and in particular crystal 
methylamphetamine, poses the highest risk to the Australian community. The following 
factors all support this conclusion: 
  the rapid growth of the methylamphetamine problem across cities, regional and 
remote communities
  the harms methylamphetamine poses to the individual, including psychosis and other 
long term psychological and behavioural problems
  the links between methylamphetamine use and other crime types including violent 
crimes against the person and property crime
  the harm to the community (including families of users, innocent bystanders and road 
users, frontline staff in hospitals, law enforcement and emergency services, and non-
government organisations) 
  the economic impact to governments and the community, and redirection of finite 
resources away from other harmful activity  
  the impact on legitimate industry sectors (such as the pharmaceutical, chemical and 
transport sectors) through diversion of chemicals and transport of illicit substances
  the significant profit to be made by organised crime groups in the importation, 
domestic manufacture, sale and distribution of methylamphetamine 
  the presence of both importation and domestic manufacture of methylamphetamine, 
unlike other illicit drugs.
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ROLE OF ORgANISED CRIME 
Organised crime groups, including transnational groups, are increasingly involved in the 
Australian methylamphetamine market. Some groups which traditionally focused on 
importing particular illicit drugs, such as heroin and cocaine, are now shifting the focus 
of their activities to methylamphetamine. 
The ACC’s intelligence highlights: 
  serious and organised crime groups have become entrenched in all levels of the 
Australian methylamphetamine market, with no one group dominant 
  more than 60 per cent of the entities on the National Criminal Target List7 are 
involved in the methylamphetamine and/or precursor market. Of these, more than  
80 per cent are also  involved in other drug markets
  the importation, manufacture and trafficking of methylamphetamine in Australia, 
and the importation of precursor chemicals, is supported by members of Australian-
based outlaw motorcycle gangs, Australian organised crime groups as well as persons 
of Middle Eastern, Eastern European and West African backgrounds, and Vietnamese, 
Chinese, Canadian, US and Mexican serious and organised crime groups
  serious and organised crime groups are increasingly involved in the importation and 
trafficking of precursors, are adept at exploiting regulatory weaknesses in Australia 
and overseas, and at adapting to fluctuations in precursor availability
  serious and organised crime continues to develop new methods for manufacturing 
methylamphetamine which rely primarily on uncontrolled chemicals.
Australian-based serious and organised crime groups now have far greater access to 
high purity imported methylamphetamine, precursors and pre-precursors8—through 
connections that permit the groups to engage effectively with methylamphetamine 
importing networks from a number of continents.  These groups also have ready access, 
via the internet and underground literature, to detailed information on alternative 
methylamphetamine and precursor production processes. 
7 The National Criminal Target List is a national listing of currently active and nationally significant organised criminal 
groups operating in Australia contributed to by Commonwealth, state and territory law enforcement agencies. The 
total number of entities listed is classified. 
8 The term ‘pre-precursor’ refers to a chemical substance which cannot directly be converted to methylamphetamine, 
but can be used to create a direct precursor chemical.
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cAse sTuDy 
The GlobAl meThylAmpheTAmine 
mArkeTplAce
Iranian produced methylamphetamine is being trans-shipped through South East 
Asia to Australia, and is characterised by very high purity. This indicates large-scale 
production utilising high-quality materials. West African organised crime groups 
are also prominent traffickers of methylamphetamine. Their trafficking routes 
extend to South-East Asia and the Middle East and into Europe and Australia. 
From a global perspective, there appears to currently be significant production of 
methylamphetamine in Mexico. Mexican crime groups are importing cocaine and 
methylamphetamine into Australia. 
It is now not unusual for persons of different ethnic or criminal backgrounds to 
collaborate at different stages of the methylamphetamine supply chain, or to 
collaborate on an importation or local supply. For example, methylamphetamine 
imported into Australia is likely to have passed through several countries with the 
assistance of a range of transnational crime groups.
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cAse sTuDy 
DiVersion oF chemicAls From leGiTimATe 
inDusTry For The mAnuFAcTure oF 
meThylAmpheTAmine
The ACC has identified an individual purchasing, and receiving, multiple kilograms 
of a non-controlled precursor chemical from a domestic supplier. The seller was 
identified to be the proprietor of a legitimate chemical supply company. Purchases 
by individuals, particularly in large quantities, are generally suspicious as the 
precursor chemical can be used in clandestine laboratories to produce either or both 
of two illicit drugs. In this particular case, there was evidence that the chemical was 
intended for use in illicit drug production.
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rolE oF orGANISEd CrIME (CoNTINuEd) 
Diversion of legitimate chemicals continues to be exploited by organised crime. Diversion 
has been identified to be occurring from the Australian chemical industry, the legitimate 
transport chain, waste destruction facilities, break and enters at pharmacies and use of 
trusted insiders. 
Several instances have been identified in which organised crime group members, or their 
associates, have established a chemical-related business with the intention of appearing 
legitimate and using it as a cover for purchasing and possessing precursors. 
Australian organised crime groups are also involved in all stages of the 
methylamphetamine market. Organised crime groups often establish partnerships to 
exploit their wide drug distribution networks, as well as their involvement in legitimate 
industries, such as the transport sector, licensed premises and security companies. Some 
groups have used their member network to expand the methylamphetamine market, 
including to regional, rural and remote areas which have not previously been exploited 
by organised crime groups.
These mutually-beneficial partnerships have also enabled the laundering of illicit profits 
made from methylamphetamine. Organised crime groups that have cooperated in 
relation to methylamphetamine use those same connections to facilitate the movement 
of proceeds of crime, particularly off-shore. This money is often reinvested into criminal 
activity. Proceeds of other criminal activity, such as cannabis production, have been used 
to fund methylamphetamine importation. Such involvement has potentially broadened 
methylamphetamine sourcing and distribution capabilities.
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cAse sTuDy 
ouTlAW moTorcycle GAnG inVolVemenT 
in The meThylAmpheTAmine mArkeT 
In 2010, the rebels Motorcycle Club established a chapter in Mildura, Victoria and 
subsequently entrenched themselves in the area. Members of this crime group 
commenced trafficking large quantities of methylamphetamine into Mildura by 
deliberately targeting youth to distribute the drugs at nightclubs and parties. 
Eventually, members of the Comanchero oMCG allegedly took over this drug trade 
and employed violence and intimidation to consolidate their position in the area.
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use AnD hArms
AUSTRALIAN METHYLAMPHETAMINE USERS 
Australian drug users now prefer crystal methylamphetamine over the powder form. 
Crystal methylamphetamine is perceived to be more desirable by users as it can be 
smoked rather than injected and perceived to be more potent or ‘purer’ than powder. 
Methylamphetamine is highly addictive and is used more often and for longer periods 
than other drugs. 
There is also a greater tendency toward poly-drug use across Australia’s illicit drug 
market, increasing the pool of methylamphetamine users. Organised crime groups are 
reflecting this trend by now dealing in multiple illicit drug types and mixing other illicit 
drugs into methylamphetamine in an attempt to increase addiction levels.
These factors, and the ready availability of methylamphetamine, have created new 
demand in areas where the drug has not previously been present. This includes regional, 
rural and remote communities.
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This 2013 National Drug Strategy Household Survey report 
shows that:
•	 fewer	Australians	are	smoking	daily	and	are	smoking	 
less cigarettes
•	 fewer	people	are	exceeding	the	lifetime	risk	and	single	
occasion	risk	guidelines	for	alcohol	use
•	 overall	illicit	drug	use	has	remained	stable	but	some	
drugs	have	declined	and	some	have	increased
•	 alcohol	continues	to	be	the	drug	of	most	concern	to	
the	community	but	an	increasing	number	of	people	are	
concerned	about	meth/amphetamines.	
2013
National Drug Strategy 
Household Survey 
detailed report
user DATA 
The nATionAl DruG sTrATeGy householD 
surVey
According to the 2013 National drug Strategy Household Survey (NdSHS), 7 per cent 
of the Australian population ged 14 years or older reported using amphetamine 
or methylamphetamine at least once in their lifetime. In the same survey, 
2.1 per cent reported recent9 amphetamine or methylamphetamine use. These 
figures remain unchanged from those reported in 2010. The reported use of powder 
methylamphetamine decreased from 51 per cent in 2010 to 29 per cent in 2013, 
while the reported use of crystal methylamphetamine more than doubled,  
increasing from 22 per cent in 2010 to 50 per cent in 2013. There has also been an 
increase in the reported frequency of use, with the proportion of users reporting 
daily or weekly use of methylamphetamine increasing from 9.3 per cent in 2010 to 
15.5 per cent in 2013. of note was the reported increase in daily or monthly crystal 
methylamphetamine use, which more than doubled, increasing from  
12.4 per cent in 2010 to 25.3 per cent in 2013.
9 In the NDSHS, ‘recent use’ refers to reported use in the 12 months preceding interview.
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HARMS ASSOCIATED WITH METHYLAMPHETAMINE
Personal harm 
Psychological, medical and social consequences of methylamphetamine use are as 
devastating to the community as they are to the individual user. There are a number of 
key impacts to users and the community:
  methylamphetamine users, particularly crystal methylamphetamine users, are at 
increased risk of a range of health-related harms, most notably increased risk of 
psychosis and mental illness. Long-term use can result in memory loss, aggression, 
increased risk of heart failure and stroke 
  crystal methylamphetamine users are more likely to demonstrate violent behaviours, 
including assaults and sexual assaults. These harms have placed significant demands 
on the resources of the health care system which treats both users and victims of 
the violent behaviour. Crystal methylamphetamine also poses risks to front-line law 
enforcement and health care officers, as well as the family and friends of drug users 
or manufacturers
  children present in the homes of methylamphetamine users or manufacturers 
are particularly at risk of ingesting associated chemicals. Additionally, many 
methylamphetamine users are likely to neglect parenting responsibilities and expose 
children to additional illegal activities
  illicit drug use is of concern in Indigenous communities throughout Australia, 
particularly so for methylamphetamine use. According to available data on  
self-reported use of illicit substances, methylamphetamine is the third most 
common illicit substance used in Indigenous communities, with 5 per cent indicating 
amphetamines/speed use in the 12 months prior to survey.10 Some of the adverse 
consequences stemming from drug use and dependency voiced in many Indigenous 
communities included domestic violence, tensions from sourcing money for 
substance use, declining participation in community life, child neglect and sexual 
exploitation of young people. 
10 Australian Institute of Health and Welfare (AIHW) 2011, Substance use among Aboriginal and Torres Strait Islander people, 
AIHW, Canberra, viewed 20 May 2013, <http://www.aihw.gov.au/publication-detail/?id=10737418268>. 
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The link beTWeen meThylAmpheTAmine use 
AnD psychosis
Many studies have found a correlation between methylamphetamine use 
and psychosis. A recent Australian study concluded that users of crystal 
methylamphetamine are five times more likely to suffer psychotic symptoms 
while taking the drug than when they were abstinent. The research studied 278 
methylamphetamine users from Sydney and Brisbane between 2006 and 2010 and 
excluded anyone with existing psychotic tendencies. The incidence of psychosis 
increased sharply from 7 per cent to 48 per cent as a consequence of the quantity  
of methylamphetamine used by the subjects. The rate of psychosis reported by  
those who also reported frequent use of cannabis and/or alcohol ranged between  
61 per cent and 69 per cent.11 
11 McKetin, R, Lubman D, Baker, A, Dawe, S, Ali, R 2013, ‘Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users 
Evidence from a Prospective Longitudinal Study’, JAMA Psychiatry. vol. 70(3), pp. 319–323.  
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HArMS ASSoCIATEd WITH METHylAMPHETAMINE (CoNTINuEd)
Manufacture 
Operators of clandestine laboratories manufacturing methylamphetamine often 
have little concern for the environment, or for public safety. Methylamphetamine 
manufacture in clandestine laboratories has resulted in explosions which have severely 
damaged properties and resulted in serious injuries and death. These labs are often 
located in residential areas, therefore posing a risk to the surrounding community. 
It is estimated that a clandestine laboratory manufacturing methylamphetamine 
generates up to 10 kilograms of hazardous and toxic waste for each kilogram of pure 
methylamphetamine produced. Toxic chemicals and residues have been found dumped 
into drains, rivers, public parks, on roadsides and in sewerage systems, posing immediate 
and long-term environmental health risks.
The chemicals and equipment used in clandestine laboratories manufacturing 
methylamphetamine and the toxic gases produced are extremely dangerous and pose 
severe health risks, not only to the occupants of the premises, but also to local residents 
and emergency personnel. The greatest immediate risks are chemical burns and 
respiratory damage for persons exposed to the release of reagents12 or the by-products 
from chemical fires and explosions at clandestine laboratory sites. 
Crime 
A range of criminal activity is associated with methylamphetamine use and 
manufacture,  including property offences, money laundering, firearms trafficking and 
violence. Intelligence also indicates that a number of crime groups represented in the 
methylamphetamine market are also involved in firearms trafficking, with some of these 
groups suspected of being involved in the ongoing supply of firearms and drugs in a 
number of states. 
A number of organised crime groups in the methylamphetamine market have been 
linked to murders and violent assaults to protect or increase their market share, or for 
reasons unrelated to their drug manufacture and supply. Extortion is another potentially 
violent activity for which groups represented in the methylamphetamine market have 
regularly come to notice. 
12 Reagents are substances used to cause a chemical reaction that modifies a precursor’s molecular structure. For example, when 
hydriodic acid and red phosphorous are mixed with the precursors ephedrine or pseudoephedrine, the resulting compound is 
methylamphetamine.  
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The link beTWeen meThylAmpheTAmine 
AnD Violence 
one of the most publicised psychological manifestations of regular 
methylamphetamine use is aggression, sometimes accompanied by violence. A 2006 
St Vincent’s Hospital study of the characteristics of methylamphetamine-related and 
other non-methylamphetamine-related presentations to the Emergency department 
found that methylamphetamine users were more aggressive, violent and dangerous 
than persons not under the influence of methylamphetamine.13 This poses a safety 
risk to hospital staff and other personnel. Extremely agitated and aggressive patients 
accounted for 18 per cent and violent and self-destructive patients accounted for 
3 per cent of methylamphetamine-related presentations. These figures were much 
higher compared with the non-methylamphetamine-related presentations, which 
recorded presentation rates of 2 per cent extremely agitated and aggressive patients 
and a figure of nil for recorded violent and self-destructive patients. 
13 Bunting, PJ, Fulde, GWO & Forster, SL 2007, ‘Comparison of crystalline methamphetamine (‘ice’) users and other patients with 
toxicology–related problems presenting to a hospital emergency department’, Medical Journal of Australia, vol. 187(10), pp. 
564-566, viewed 14 May 2013, <https://www.mja.com.au/journal/2007/187/10 /comparison-crystalline- methamphetamine-
ice-users-and-other-patients-toxicology>.  
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ouTlook 
 
The methylamphetamine market will almost certainly remain entrenched and continue 
to grow in the medium term. Proceeds from this market will continue to drive the illicit 
economy. Innovative money laundering methodologies will likely be seen in attempts to 
conceal the profits. At least some of these illicit profits will be re-invested into the illicit 
drug market.
Transnational organised crime involvement in the Australian methylamphetamine 
and precursor markets is entrenched, and will likely expand in the medium term. The 
highly lucrative nature of the Australian market, combined with the availability and 
relatively low cost of methylamphetamine and precursors internationally, will sustain this 
involvement. 
Looking through the lens of supply reduction, there is currently an unprecedented level 
of organised crime involvement in high-volume importation and trafficking of precursors 
internationally and domestically. These groups have repeatedly demonstrated their 
ability to adapt rapidly and dynamically to changes in legislation, law enforcement 
targeting and the market. They have been seen to adjust their sourcing, diversion and 
importation methods, chemical choices and manufacturing methodologies to adapt 
to market changes and avoid detection. When these factors are combined with the 
tendency of groups to diversify their range of illicit commodities, some organised crime 
groups will be particularly resilient to law enforcement disruption efforts. 
The addictive nature of methylamphetamine, combined with increasing user numbers, 
will likely create an increased burden on law enforcement and the health sector. 
Violent behaviour associated with methylamphetamine use, particularly crystal 
methylamphetamine use, is likely to involve non-users, such as first responders, hospital 
staff and members of the community. The increase in addiction-related crimes such as 
burglaries and violent assaults and drug-impaired driving will also place an increased 
burden on law enforcement agencies, and increase public concern.
The introduction in Australia of controls over many precursor chemicals has led to 
a decline in identified domestic diversion of traditional precursors. However, these 
restrictions appear to have been one factor in the growth in precursors illicitly imported 
and in the diversion of a broader range of non-controlled chemicals for domestic 
manufacture of precursors and drugs using novel methods.
It has long been recognised that responses to the methylamphetamine market are 
best driven by an overarching national strategy and coordinated multi-agency policy, 
legislative, regulatory, intelligence and investigative activities. In addition to law 
enforcement, the health sector, industry, educators and the not-for-profit sector share 
important components of the response.
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DeFiniTions
AMPHETAMINE-TyPE STIMulANTS
Some data received by the ACC and included in ACC assessments refers to the 
more generic term amphetamine-type stimulants, which includes substances other 
than methylamphetamine, e.g. amphetamine and phenethylamines including 3,4- 
methylenedioxymethylamphetamine (MDMA, ‘ecstasy’). This is the result of historical 
data recording practices. The term amphetamine-type stimulants will be retained in some 
circumstances in this report, with the range of substances included noted where possible.
ClANdESTINE lABorATorIES
A clandestine laboratory (also known as a ‘clan lab’) refers to any operation in which 
illicit drugs are covertly manufactured. These facilities range from crude, improvised 
processes to dedicated operations utilising complex processes and equipment capable of 
producing large amounts of methylamphetamine. 
CRYSTAL METHYLAMPHETAMINE
There is a common—if often erroneous—perception held by the public, users 
and sometimes within government agencies that crystal methylamphetamine 
is a more potent and/or pure form of methylamphetamine. While this is often 
the case, appearance alone is not a reliable indicator of purity. The terms crystal 
methylamphetamine and ice are used inter-changeably.
METHYLAMPHETAMINE
Although the terms ‘methylamphetamine’ and ‘methamphetamine’ are synonymous, 
and both terms are used in different Australian legislation, the ACC uses the term 
‘methylamphetamine’. 
Methylamphetamine has four common forms—tablet, powder (‘speed’), crystal (‘ice’) 
and oil. Methylamphetamine can be swallowed, snorted, smoked or injected. Crystal 
methylamphetamine is generally heated and the vapours inhaled. It can also be injected 
after being dissolved in water.
PRECURSOR
The term precursor is used to refer to any chemical substance which can be used to 
produce methylamphetamine. The term ‘pre-precursor’ refers to a chemical substance 
which cannot directly be converted to methylamphetamine, but can be used to create a 
direct precursor chemical.
WHERE TO gO FOR MORE INFORMATION 
Everyone can play a role in responding to organised criminal activity in  
Australia by reporting suspicious activity to your local police or  
calling Crime Stoppers on 1800 333 000. 
 
For more information visit www.crimecommission.gov.au. 
For health and educational material visit www.drugs.health.gov.au.
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